Bacillus Calmette Guerin(Massachusetts General Hospital)

卡介苗芽孢杆菌(Massachusetts General Hospital)

Report date: 2023/05/22 20:00:22

Base Information

Drug NameBacillus Calmette Guerin(Massachusetts General Hospital)
Drug Alias NameBCG(Massachusetts General Hospital)Bacillus Calmette-Guerin(Massachusetts General Hospital)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General Hospital
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A